1264 related articles for article (PubMed ID: 17954710)
1. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
2. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
[TBL] [Abstract][Full Text] [Related]
3. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
4. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
Wakelee H; Dubey S; Gandara D
Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
6. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
Geiger S; Schlemmer M; Heinemann V; Stemmler HJ
Anticancer Drugs; 2010 Oct; 21(9):799-804. PubMed ID: 20679887
[TBL] [Abstract][Full Text] [Related]
9. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
Baumann M
Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
[No Abstract] [Full Text] [Related]
10. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
Bernstein ED; Herbert SM; Hanna NH
Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
12. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
Socinski MA
Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P
Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Dunant A; Pignon JP; Le Chevalier T
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
[TBL] [Abstract][Full Text] [Related]
15. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
16. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
Yamaguchi M; Fukuyama Y; Ichinose Y
Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
Nakajima E; Katou H
Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
de Boer RH; Smith IE; Pastorino U; O'Brien ME; Ramage F; Ashley S; Goldstraw P
Br J Cancer; 1999 Mar; 79(9-10):1514-8. PubMed ID: 10188899
[TBL] [Abstract][Full Text] [Related]
20. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
Wakelee HA; Stephenson P; Keller SM; Wagner H; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
Lung Cancer; 2005 Jun; 48(3):389-97. PubMed ID: 15893008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
